BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21131689)

  • 1. A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
    Rodrigues J; Cancho VG; de Castro M; Balakrishnan N
    Stat Methods Med Res; 2012 Dec; 21(6):585-97. PubMed ID: 21131689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxed Poisson cure rate models.
    Rodrigues J; Cordeiro GM; Cancho VG; Balakrishnan N
    Biom J; 2016 Mar; 58(2):397-415. PubMed ID: 26686485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destructive weighted Poisson cure rate models.
    Rodrigues J; de Castro M; Balakrishnan N; Cancho VG
    Lifetime Data Anal; 2011 Jul; 17(3):333-46. PubMed ID: 21076872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatiotemporal Bayesian inference dipole analysis for MEG neuroimaging data.
    Jun SC; George JS; Paré-Blagoev J; Plis SM; Ranken DM; Schmidt DM; Wood CC
    Neuroimage; 2005 Oct; 28(1):84-98. PubMed ID: 16023866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability dynamics of a repopulating tumor in case of fractionated external radiotherapy.
    Stavreva N; Stavrev P; Fallone BG
    Phys Med; 2009 Dec; 25(4):181-91. PubMed ID: 19345599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference for stochastic kinetic models using a diffusion approximation.
    Golightly A; Wilkinson DJ
    Biometrics; 2005 Sep; 61(3):781-8. PubMed ID: 16135029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian latent variable models for mixed discrete outcomes.
    Dunson DB; Herring AH
    Biostatistics; 2005 Jan; 6(1):11-25. PubMed ID: 15618524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
    de Gunst MC; Dewanji A; Luebeck EG
    Stat Med; 2003 May; 22(10):1691-707. PubMed ID: 12720305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian cure rate models induced by frailty in survival analysis.
    de Souza D; Cancho VG; Rodrigues J; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2011-2028. PubMed ID: 28656796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
    Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
    Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach for handling longitudinal count data with zero-inflation and overdispersion: poisson geometric process model.
    Wan WY; Chan JS
    Biom J; 2009 Aug; 51(4):556-70. PubMed ID: 19650053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependent.
    Shkedy Z; Molenberghs G; Van Craenendonck H; Steckler T; Bijnens L
    J Biopharm Stat; 2005; 15(2):225-39. PubMed ID: 15796291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian analysis of the differences of count data.
    Karlis D; Ntzoufras I
    Stat Med; 2006 Jun; 25(11):1885-905. PubMed ID: 16252270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor unit number estimation--a Bayesian approach.
    Ridall PG; Pettitt AN; Henderson RD; McCombe PA
    Biometrics; 2006 Dec; 62(4):1235-50. PubMed ID: 17156299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Bayesian inference to characterize risks associated with low doses of low-LET radiation.
    Schöllnberger H; Scott BR; Hanson TE
    Bull Math Biol; 2001 Sep; 63(5):865-83. PubMed ID: 11565407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.